Literature DB >> 8148926

Plasma cholecystokinin and pancreatic polypeptide secretion in response to bombesin, meal ingestion and modified sham feeding in lean and obese persons.

R J Lieverse1, A A Masclee, J B Jansen, C B Lamers.   

Abstract

Disturbed satiety mechanisms may contribute to obesity. There has been speculation that cholecystokinin (CCK) and pancreatic polypeptide (PP) are involved in the regulation of satiety. We have therefore investigated whether there are differences between healthy lean and healthy non-diabetic obese volunteers in plasma CCK or PP release after a neuropeptidergic stimulation with bombesin and after infusion of a mixed meal. There were no differences in plasma CCK between groups either basally or in response to either form of stimulation. However, the plasma PP concentrations after the meal were significantly less in obese (2845 +/- 404 pM.min) than in lean subjects (5569 +/- 997 pM.min), whereas the plasma PP concentrations during bombesin were similar in both groups. We tested two other groups of nine obese and lean subjects to determine whether a disturbed vagal function could be the cause of the diminished plasma PP in obese persons, by studying the effect of modified sham feeding (MSF) on plasma PP. However, there were no significant differences in the plasma PP response to MSF between lean and obese subjects. We conclude that there are no differences between lean and obese persons in plasma CCK secretion in response to infusion of the neuropeptide bombesin or to ingestion of a mixed meal. However, the plasma PP after a mixed meal, is markedly diminished in obese subjects. This could not be attributed to a disturbed vagal cephalic stimulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148926

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  11 in total

1.  Vagus nerve injury with severe diarrhea after laparoscopic antireflux surgery.

Authors:  Andrzej Ukleja; Timothy A Woodward; Sami R Achem
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

2.  Determinants of gallbladder kinetics in obesity.

Authors:  E M H Mathus-Vliegen; M L Van Ierland-Van Leeuwen; A Terpstra
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

Review 3.  Bariatric surgery evolution from the malabsorptive to the hormonal era.

Authors:  Ehab Akkary
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

Review 4.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Bombesin improves adaptive immunity of the salivary gland during parenteral nutrition.

Authors:  Joseph F Pierre; Aaron F Heneghan; Xinying Wang; Drew A Roenneburg; Guy E Groblewski; Kenneth A Kudsk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-10-11       Impact factor: 4.016

6.  Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity.

Authors:  Elisabeth M H Mathus-Vliegen; Gerrit H de Groot
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

7.  The cloned rat pancreatic polypeptide receptor exhibits profound differences to the orthologous receptor.

Authors:  I Lundell; M A Statnick; D Johnson; D A Schober; P Starbäck; D R Gehlert; D Larhammar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 8.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

9.  Energy homeostasis in apolipoprotein AIV and cholecystokinin-deficient mice.

Authors:  Jonathan Weng; Danwen Lou; Stephen C Benoit; Natalie Coschigano; Stephen C Woods; Patrick Tso; Chunmin C Lo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-08-02       Impact factor: 3.619

10.  Endocrine Cephalic Phase Responses to Food Cues: A Systematic Review.

Authors:  Marlou P Lasschuijt; Monica Mars; Cees de Graaf; Paul A M Smeets
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.